1. Home
  2. IOVA vs EVCM Comparison

IOVA vs EVCM Comparison

Compare IOVA & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • EVCM
  • Stock Information
  • Founded
  • IOVA 2007
  • EVCM 2006
  • Country
  • IOVA United States
  • EVCM United States
  • Employees
  • IOVA N/A
  • EVCM N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • EVCM EDP Services
  • Sector
  • IOVA Health Care
  • EVCM Technology
  • Exchange
  • IOVA Nasdaq
  • EVCM Nasdaq
  • Market Cap
  • IOVA 2.6B
  • EVCM 2.2B
  • IPO Year
  • IOVA N/A
  • EVCM 2021
  • Fundamental
  • Price
  • IOVA $7.73
  • EVCM $12.21
  • Analyst Decision
  • IOVA Strong Buy
  • EVCM Buy
  • Analyst Count
  • IOVA 9
  • EVCM 9
  • Target Price
  • IOVA $23.33
  • EVCM $12.56
  • AVG Volume (30 Days)
  • IOVA 5.4M
  • EVCM 105.8K
  • Earning Date
  • IOVA 11-07-2024
  • EVCM 11-12-2024
  • Dividend Yield
  • IOVA N/A
  • EVCM N/A
  • EPS Growth
  • IOVA N/A
  • EVCM N/A
  • EPS
  • IOVA N/A
  • EVCM N/A
  • Revenue
  • IOVA $90,858,000.00
  • EVCM $693,206,000.00
  • Revenue This Year
  • IOVA $13,758.71
  • EVCM $4.85
  • Revenue Next Year
  • IOVA $171.64
  • EVCM $4.17
  • P/E Ratio
  • IOVA N/A
  • EVCM N/A
  • Revenue Growth
  • IOVA 12751.20
  • EVCM 3.82
  • 52 Week Low
  • IOVA $6.70
  • EVCM $6.22
  • 52 Week High
  • IOVA $18.33
  • EVCM $12.35
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 34.99
  • EVCM 56.18
  • Support Level
  • IOVA $7.69
  • EVCM $11.87
  • Resistance Level
  • IOVA $8.14
  • EVCM $12.34
  • Average True Range (ATR)
  • IOVA 0.38
  • EVCM 0.52
  • MACD
  • IOVA -0.07
  • EVCM -0.04
  • Stochastic Oscillator
  • IOVA 8.77
  • EVCM 79.29

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts..

Share on Social Networks: